Hologic Inc.

Company Snapshot

Founded: 1985
Entity Type: Public
Employees: 7,063
Region: U.S.
Revenue: $4,030.3 Millions
Revenue Year: 2024
Headquarter: Marlborough, Massachusetts, U.S.
Key Geographics: U.S., Europe, Asia-Pacific, Rest of World
Corporate Address: 250 Campus Drive, Marlborough, Massachusetts 01752 U.S. Tel. +1-508-263-2900 www.hologic.com

Company Overview

Founded in 1985, Hologic develops, manufactures, and supplies diagnostics products, medical imaging systems and surgical products focused on women’s health and well being through early detection and treatment. The company operates in four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Diagnostics segment caters to the companion diagnostics market. It offers a broad range of diagnostic products, used to aid in the screening and diagnosing of human diseases. The primary Diagnostics products include molecular diagnostic assays, which run on the advanced instrumentation systems (Panther, Panther Fusion and Tigris), ThinPrep cytology system and the Rapid Fetal Fibronectin Test.

Hologic provides diagnostics solutions such as respiratory and fusion assays, genius digital imaging, oncology, cervical health, and sexual health. The company has developed many diagnostic assays, for example ThinPrep, Aptima assays and Aptima STI assays.

Financial Highlights (FY 2024)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Hologic Inc. In Reports

The Global Influenza Market

BCC Research Report: Dive into influenza market report includes global revenue ($ Million) for base year data of 2023 and estimated data for the forecast period 2024 through 2029.

Epigenetics: Technologies and Global Markets

BCC Research Report: Dive into Personalized Medicine and Epigenomics Market the report includes epigenetic research tools and reagents, drugs, and IVDs market for epigenetic products is given for 2023 and 2024 and then...

Medical Imaging: A BCC Research Outlook

BCC Research Report: Dive into medical imaging market trends, drivers, restraints, opportunities, and influencers and their impact on market revenue and growth (2024-2029).

Company's Business Segments

  • Diagnostics : Cytology & Perinatal, Molecular Diagnostics, Blood Screening
  • Breast Health : Breast Imaging, Interventional Breast Solutions
  • GYN Surgical : Myosure Hysteroscopic Tissue Removal System, Novasure Endometrial Ablation System, Fluent Fluid Management System, Acessa Provu Laparoscopic Radiofrequency Ablation System, Coolseal Vessel Sealing Portfolio, Justright Surgical Stapler
  • Skeletal Health : Horizon DXA, Fluoroscan Insight FD mini C-arm

Applications/End User Industries

  • Molecular Diagnostics
  • Cytology
  • Tests
  • Collection Devices
  • Screening Technologies